Evidence map›Paper›PMID 39122670›Full record

ArticleNature communications2024

MOCHA's advanced statistical modeling of scATAC-seq data enables functional genomic inference in large human cohorts.

Samir Rachid Zaim, Mark-Phillip Pebworth, Imran McGrath, Lauren Okada, Morgan Weiss, Julian Reading, Julie L Czartoski, Troy R Torgerson, M Juliana McElrath, Thomas F Bumol and 2 more

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Samir Rachid Zaim *Allen Institute for Immunology, Seattle, WA, USA.ORCID 0009-0007-9256-2324
Mark-Phillip Pebworth *Allen Institute for Immunology, Seattle, WA, USA.
Imran McGrathAllen Institute for Immunology, Seattle, WA, USA.
Lauren OkadaAllen Institute for Immunology, Seattle, WA, USA.ORCID 0000-0002-5691-3373
Morgan WeissAllen Institute for Immunology, Seattle, WA, USA.
Julian ReadingAllen Institute for Immunology, Seattle, WA, USA.ORCID 0000-0002-8533-3992
Julie L CzartoskiVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Troy R TorgersonAllen Institute for Immunology, Seattle, WA, USA.ORCID 0000-0003-3489-5036
M Juliana McElrathVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Thomas F BumolAllen Institute for Immunology, Seattle, WA, USA.
Peter J SkeneAllen Institute for Immunology, Seattle, WA, USA.ORCID 0000-0001-8965-5326
Xiao-Jun LiAllen Institute for Immunology, Seattle, WA, USA. xiaojun.li@alleninstitute.org.ORCID 0000-0003-0832-9479

Funding

LC: HIV Vaccine Trials NetworkUM1AI068618 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Margaret Juliana McElrath · 2011 to 2026
$483.6M
Seattle Vaccine Trials UnitUM1AI069481 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Rachel Ann Bender Ignacio, Margaret Juliana McElrath · 2012 to 2026
$24.4M
NIAID NIH HHS UM1 AI068618NIAID NIH HHS UM1 AI069481
6 · The paper itself

Abstract

Single-cell assay for transposase-accessible chromatin using sequencing (scATAC-seq) is being increasingly used to study gene regulation. However, major analytical gaps limit its utility in studying gene regulatory programs in complex diseases. In response, MOCHA (Model-based single cell Open CHromatin Analysis) presents major advances over existing analysis tools, including: 1) improving identification of sample-specific open chromatin, 2) statistical modeling of technical drop-out with zero-inflated methods, 3) mitigation of false positives in single cell analysis, 4) identification of alternative transcription-starting-site regulation, and 5) modules for inferring temporal gene regulatory networks from longitudinal data. These advances, in addition to open chromatin analyses, provide a robust framework after quality control and cell labeling to study gene regulatory programs in human disease. We benchmark MOCHA with four state-of-the-art tools to demonstrate its advances. We also construct cross-sectional and longitudinal gene regulatory networks, identifying potential mechanisms of COVID-19 response. MOCHA provides researchers with a robust analytical tool for functional genomic inference from scATAC-seq data.

Indexed as

ChromatinCOVID-19Gene Regulatory NetworksGenomicsModels, StatisticalSingle-Cell AnalysisChromatin Immunoprecipitation SequencingCohort StudiesGene Expression RegulationHumansSARS-CoV-2TransposasesChromatinTransposases

Identifiers

PMID39122670
PMCPMC11316085

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.